Sarafidis, P., Ortiz, A., Ferro, C., Halimi, J., Kreutz, R., Mallamaci, F., et al. (2022). Comment on 'Sodium-glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease' Reply. JOURNAL OF HYPERTENSION, 40(3), 624-626 [10.1097/HJH.0000000000003040].

Comment on 'Sodium-glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease' Reply

Mancia, G;
2022

Lettera in rivista
Peripheral Vascular Disease
English
2022
40
3
624
626
none
Sarafidis, P., Ortiz, A., Ferro, C., Halimi, J., Kreutz, R., Mallamaci, F., et al. (2022). Comment on 'Sodium-glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease' Reply. JOURNAL OF HYPERTENSION, 40(3), 624-626 [10.1097/HJH.0000000000003040].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/447888
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact